Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

Clinical trial NCT01854775 · COMPLETED

Trial details

NCT number: NCT01854775
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

Start date: 2013-05-06
Primary completion: 2020-05-11
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.